Marlowe plc (MRL) - Total Liabilities

Latest as of March 2025: GBX97.60 Million GBX ≈ $11.88K USD

Based on the latest financial reports, Marlowe plc (MRL) has total liabilities worth GBX97.60 Million GBX (≈ $11.88K USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Marlowe plc to assess how effectively this company generates cash.

Marlowe plc - Total Liabilities Trend (2008–2025)

This chart illustrates how Marlowe plc's total liabilities have evolved over time, based on quarterly financial data. Check Marlowe plc (MRL) asset resilience to evaluate the company's liquid asset resilience ratio.

Marlowe plc Competitors by Total Liabilities

The table below lists competitors of Marlowe plc ranked by their total liabilities.

Company Country Total Liabilities
Arcontech Group Plc
LSE:ARC
UK GBX2.17 Million
PowerHouse Energy Group Plc
LSE:PHE
UK GBX564.54K
Nexus Infrastructure plc
LSE:NEXS
UK GBX24.35 Million
Braime Group PLC
LSE:BMT
UK GBX15.38 Million
Pod Point Group Holdings PLC
LSE:PODP
UK GBX38.16 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Marlowe plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see MRL company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.42 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.52 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.34 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Marlowe plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Marlowe plc (2008–2025)

The table below shows the annual total liabilities of Marlowe plc from 2008 to 2025.

Year Total Liabilities Change
2025-03-31 GBX97.60 Million
≈ $11.88K
-78.45%
2024-03-31 GBX452.80 Million
≈ $55.09K
+10.95%
2023-03-31 GBX408.10 Million
≈ $49.65K
+18.22%
2022-03-31 GBX345.20 Million
≈ $42.00K
+187.19%
2021-03-31 GBX120.20 Million
≈ $14.62K
+5.81%
2020-03-31 GBX113.60 Million
≈ $13.82K
+59.77%
2019-03-31 GBX71.10 Million
≈ $8.65K
+112.24%
2018-03-31 GBX33.50 Million
≈ $4.08K
+63.41%
2017-03-31 GBX20.50 Million
≈ $2.49K
+561.29%
2016-03-31 GBX3.10 Million
≈ $377.18
+14661.90%
2015-03-31 GBX21.00K
≈ $2.56
0.00%
2014-03-31 GBX21.00K
≈ $2.56
+5.00%
2013-03-31 GBX20.00K
≈ $2.43
+5.26%
2012-03-31 GBX19.00K
≈ $2.31
+26.67%
2011-03-31 GBX15.00K
≈ $1.83
-16.67%
2010-03-31 GBX18.00K
≈ $2.19
-73.53%
2009-03-31 GBX68.00K
≈ $8.27
+94.29%
2008-03-31 GBX35.00K
≈ $4.26
--

About Marlowe plc

LSE:MRL UK Security & Protection Services
Market Cap
$122.94K
GBX1.01 Billion GBX
Market Cap Rank
#30928 Global
#1079 in UK
Share Price
GBX12.84
Change (1 day)
+0.94%
52-Week Range
GBX12.37 - GBX445.00
All Time High
GBX791.54
About

Marlowe plc provides business-critical services in the United Kingdom. The company offers fire risk assessments, design and installation of fire systems, monitoring and maintenance, design and installation of security systems, security monitoring solutions, and technical support services. It also offers water treatment, water and air hygiene compliance, wastewater and effluent treatment, ventilat… Read more